Management Series

Practical Applications and Clinical Advances in Multiple Myeloma: Options Spanning the Spectrum of Care

Modules

• Mechanisms of Action and Clinical Advances in the Treatment of Multiple Myeloma
• Clinical Considerations and Implications for Optimizing Patient Outcomes in Multiple Myeloma

Interactive Virtual Presentations

• Newly Diagnosed Multiple Myeloma in Transplantation-Eligible Patients
• Slideset: Newly Diagnosed Multiple Myeloma in Transplantation-Eligible Patients
• Treatment of Newly Diagnosed Myeloma Patients Who Are Not Candidates for ASCT
• Slideset: Treatment of Newly Diagnosed Myeloma Patients Who Are Not Candidates for ASCT
• Treatment of Patients With Relapsed or Refractory Multiple Myeloma
• Slideset: Treatment of Patients With Relapsed or Refractory Multiple Myeloma

CCO Slideset

• Pharmacological and Clinical Nursing Considerations in the Treatment of Multiple Myeloma

Spanning the Spectrum of Care: Clinical Advances and Practical Applications in Lymphoma

Modules

• Mechanisms of Action and Clinical Advances in the Treatment of Non-Hodgkin’s Lymphomas
• Clinical Considerations and Implications for Optimizing Outcomes in Patients With NHL

Interactive Virtual Presentations

• Evolving Options and Challenges in Mantle Cell Lymphoma
• Slideset: Evolving Options and Challenges in Mantle Cell Lymphoma
• Indolent B-Cell Disorders: Follicular Lymphoma and Waldenström’s Macroglobulinemia
• Slideset: Indolent B-Cell Disorders: Follicular Lymphoma and Waldenström’s Macroglobulinemia
• Therapeutic Approaches in T-Cell Lymphomas: PTCL and CTCL
• Slideset: Therapeutic Approaches in T-Cell Lymphomas: PTCL and CTCL
• Clinical Considerations and Strategies for Managing Patients With DLBCL
• Slideset: Clinical Considerations and Strategies for Managing Patients With DLBCL

CCO Slideset

• Overview of Treatment Options and Clinical Considerations for Managing NHL Patients

Management of ER+ Postmenopausal Early Breast Cancer

Virtual Presentations

• The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer
• Slideset: The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer
• Current Hormonal Therapy Strategies for ER-Positive Postmenopausal Breast Cancer
• Slideset: Current Hormonal Therapy Strategies for ER-Positive Postmenopausal Breast Cancer
• Evaluating Long-Term Safety of Aromatase Inhibitors
• Slideset: Evaluating Long-Term Safety of Aromatase Inhibitors
• Patient Case: Treatment Options for an ER-Positive Postmenopausal Woman With Early Breast Cancer

CME Modules

• The Role of Predictive Factors in Guiding Treatment Decisions for Estrogen Receptor–Positive Postmenopausal Breast Cancer
• Current Hormonal Therapy Strategies for Estrogen Receptor–Positive Postmenopausal Breast Cancer
• Evaluating Long-Term Safety of Aromatase Inhibitors

Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

Modules

• Current Clinical Data on Adjuvant Therapy for HER2-Positive Breast Cancer
• Estimating Benefit and Prognosis With Adjuvant Therapy for HER2-Positive Breast Cancer

Interactive Case Challenges

• Treatment of a 32-Year-Old Patient With HER2-Positive Breast Cancer
• Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes

CCO Slideset

• Assessing Breast Cancer Prognosis and Applications for Clinical Practice

Research Priorities in Colorectal Cancer: Recommendations of the Scientific Leadership Council in GI Cancer of the Coalition of Cancer Cooperative Groups

Modules

• Colorectal Cancer: Demographics and Screening
• Colorectal Cancer Prevention
• Colorectal Cancer Detection and Diagnosis
• Adjuvant Treatment for Rectal Cancer
• Adjuvant Treatment for Colon Cancer
• Advanced Colorectal Cancer and Novel Therapies

Research Priorities in Non-Small-Cell Lung Cancer

Modules

• Barriers to Clinical Trial Accrual and Recommendations for Improvement
• Adjuvant and Neoadjuvant Therapy for Early-Stage NSCLC
• Screening and Imaging in NSCLC
• First-Line and Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer
• Novel Therapeutic Approaches